Dapsone’s Double Edge: How a 1940s Leprosy Drug Still Fights Resistance and Triggers Danger
A new review explains how dapsone remains central to leprosy treatment while its metabolism drives anemia, methemoglobinemia and hypersensitivity risks.
A new review explains how dapsone remains central to leprosy treatment while its metabolism drives anemia, methemoglobinemia and hypersensitivity risks.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.